Life Sciences Review : New categories of emerging biologics and advances in cell and gene therapies are driving an evolutionary change in the contract research organization industry as these companies adapt their organizations to supply the services needed today. The rapid growth and uptake of technologies, such as CRISPR, CAR T cells, bispecifics and more, are significantly influencing the landscape of biotech and pharma drug development. To keep pace and provide the required support, CROs are investing in cutting-edge science and growing their service offerings to facilitate the field.

Check Out This : Life Sciences review